How should rectal cancers with synchronous metastases be managed?;Comment prendre en charge les cancers du rectum avec métastases synchrones?

Gastroenterologie Clinique et Biologique

Volumn 31, Issue HS1, 2007, Pages

  Benoist, Stéphane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; LIVER CARCINOMA; METASTASIS POTENTIAL; NOTE; PREOPERATIVE EVALUATION; RECTUM CANCER;

EID: 34347361434     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (74)

1. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 1997;84:1731-6.
2. McArdle CS, Hole D, Hansell D, Blumgart LH, Wood CB. Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg 1990;77:280-2.
3. Sarela A, O'Riordain DS. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001;88:163-4.
4. Laurent C, Rullier E. Colorectal cancer and hepatitis synchronous metastases: should the primary tumor be resected. Gastroenterol Clin Biol 2004;28:431-2.
5. Skibber J. Operative intervention for primary tumors in stage IV colorectal cancer. Ann Surg Oncol 1999;6:629-30.
6. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
7. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
8. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1,568 patients. Association Française de Chirurgie. Cancer 1996;77:1254-62.
9. Becouam Y, Blanc-Vincent MP, Lasser P, Dubois JB, Ducreux M, Giovannini M, et al. Standards, options et recommandations pour la prise en charge des patients atteints d'adénocarcinome primitif du rectum. Presse Med 1999;28:1367-74.
10. National Comprehensive Cancer Network: Clinical Practice Guidelines. http://www.nccn.org/physician_gls/f_guidelines.html
11. Pasetto LM, Rossi E, Paris MK, Lonardi S, Monfardini S. Common management of primary rectal carcinoma in patients with stage IV disease at the diagnosis. Anticancer Res 2003;23:4999-5004.
12. Chu QD, Davidson RS, Rodriguez-Bigas MA, Wirtzfeld DA, Petrelli NJ. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum? J Surg Oncol 2002;81:3-7.
13. Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 2004;22:3475-84.
14. de Santibanes E, Lassalle FB, McCormack L, Pekolj J, Quintana GO, Vaccaro C, et al. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg 2002;195:196-202.
15. Tocchi A, Mazzoni G, Brozzetti S, Miccini M, Cassini D, Bettelli E. Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis 2004;19:580-5.
16. Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 2000;30:7-11.
17. Nash GM, Saltz LB, Kemeny NE, Minsky B, Sharma S, Schwartz GK, et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002;9:954-60.
18. Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650-9.
19. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003;197:233-41.
20. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003;90:956-62.
21. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
22. Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003;57:84-9.
23. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999;44:1027-38.
24. Bozzetti F, Andreola S, Baratti D, Mariani L, Stani SC, Valvo F, et al. Preoperative chemoradiation in patients with resectable rectal cancer: results on tumor response. Ann Surg Oncol 2002;9:444-9.
25. François Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396.
26. Freyer G, Bossard N, Romestaing P, Mornex F, Chapet O, Trillet-Lenoir V, et al. Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 2001;19:2433-8.
27. Gérard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-24.
28. Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003;55:132-7.
29. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-7.
30. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-47.
31. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-14.
32. Elias D, Detroz B, Lasser P, Plaud B, Jerbi G. Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg 1995;169:254-60.
33. Jaeck D, Bachellier P, Weber JC, Boudjema K, Mustun A, Paris F, et al. Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients. Chirurgie 1999;124:258-63.
34. Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG, Nagorney DM. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 2004;47:1310-6.
35. Lambert LA, Colacchio TA, Barth RJ Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000;135:473-9.
36. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109-15.
37. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, et al. Two-stage liver surgery for advanced liver metastasis synchronous with colorectal tumor. Hepatogastroenterology 2004;51:413-8.
38. Peeters CF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Ruers TJ. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer 2004;112:554-9.
39. Kimura F, Miyazaki M, Suwa T, Kakizaki S, Itoh H, Kaiho T, et al. Reduced hepatic acute-phase response after simultaneous resection for gastrointestinal cancer with synchronous liver metastases. Br J Surg 1996;83:1002-6.
40. e congrès français de chirurgie. Eds Springer: Paris, 1992:1-181.
41. Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846-50.
42. Longo WE, Ballantyne GH, Bilchik AJ, Modlin IM. Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988;31:842-7.
43. Fitzgerald SD, Longo WE, Daniel GL, Vernava AM 3rd. Advanced colorectal neoplasia in the high-risk elderly patient: is surgical resection justified? Dis Colon Rectum 1993;36:161-6.
44. Johnson WR, McDermott FT, Pihl E, Milne BJ, Price AB, Hughes ES. Palliative operative management in rectal carcinoma. Dis Colon Rectum 1981;24:606-9.
45. Baigrie RJ, Berry AR. Management of advanced rectal cancer. Br J Surg 1994;81:343-52.
46. Crane CH, Janjan NA, Abbruzzese JL, Curley S, Vauthey J, Sawaf HB, et al. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys 2001;49:107-16.
47. Myint AS. The role of radiotherapy in the palliative treatment of gastrointestinal cancer. Eur J Gastroenterol Hepatol 2000;12:381-90.
48. Stipa F, Lucandri G, Ferri M, Casula G, Ziparo V. Local excision of rectal cancer with transanal endoscopic microsurgery (TEM). Anticancer Res 2004;24:1167-72.
49. Türler A, Schäfer H, Pilchmaier H. Role of transanal endoscopic surgery in palliative treatment of rectal cancer. Scand J Gastroenterol 1997;32:58-61.
50. Kimmey MB. Endoscopic methods (other than stents) for palliation of rectal carcinoma. J Gastrointest Surg 2004;8:270-3.
51. Fazio VW. Indications and surgical alternatives for palliation of rectal cancer. J Gastrointest Surg 2004;8:262-5.
52. Jakobs R, Miola J, Eickhoff A, Adamek HE, Riemann JF. Endoscopic laser palliation for rectal cancer. Therapeutic outcome and complications in eighty-three consecutive patients. Z Gastroenterol 2002;40:551-6.
53. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Sur 2003;196:722-8.
54. Julianov A, Stoyanov H. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001;88:1264.
55. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000;321:531-5.
56. Donovan MP, Yeung ST, John TG, Rees M. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001;88:1016-7.
57. Elias D. Colorectal cancer with synchronous liver metastases: is it always necessary to resect primary tumor? Ann Chir 2002;127:665-6.
58. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229-37.
59. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Sur 2004;240:644-57.
60. Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vauthey JN, et al. Surgery after downstaging of unresectable hepatic tumors with intraarterial chemotherapy. Ann Surg Oncol 2000;7:490-5.
61. Rivoire M, De Cian F, Meeus P, Negrier S, Sebban H, Kaemmerlen P. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 2002;95:2283-92.
62. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003;90:963-9.
63. Al-Sanea N, Isbister WH. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control? ANZ J Surg 2004;74:229-32
64. Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Cheng S, Chen cm. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003;46:1646-52.
65. Milsom JW, Kim SH, Hammerhofer KA, Fazio VW. Laparoscopic colorectal cancer surgery for palliation. Dis Colon Rectum 2000;43:1512-6.
66. Cummins ER, Vick KD, Poole GV. Incurable colorectal carcinoma: the role of surgical palliation. Am Surg 2004;70:433-7.
67. Mahteme H, Pahlman L, Glimelius B, Graf W. Prognosis after surgery in patients with incurable rectal cancer: a population-based study. Br J Surg 1996;83:1116-20.
68. Law WL, Chan WF, Lee YM, Chu KW. Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis 2004;19:197-202.
69. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530-4.
70. Sarela AI, Guthrie JA, Seymour MT, Ride E, Guillou PJ, O'Riordain DS. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001;88:1352-6.
71. Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003;52:568-73.
72. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-7.
73. Michel P, Roque I, Di Fiore F, Langlois S, Scotte M, Teniere P, et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 2004;28:434-7.
74. Pautrat K, Benoist S, Mitry E, Penna C, Rougier P, Nordlinger B. Fautil réséquer la tumeur primitive en cas de cancer colorectal avec métastases hépatiques (MH) synchrones non résécables ? Étude cas-témoins chez 59 malades. Ann Chir 2003;128:657.